Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Recent developments in emerging microimmunoassays.

Woolley CF, Hayes MA.

Bioanalysis. 2013 Jan;5(2):245-64. doi: 10.4155/bio.12.298. Review.

2.

Emerging technologies for biomedical analysis.

Woolley CF, Hayes MA.

Analyst. 2014 May 21;139(10):2277-88. doi: 10.1039/c4an00259h. Review.

PMID:
24658814
3.

Advances in immunoassay technology.

Self CH, Cook DB.

Curr Opin Biotechnol. 1996 Feb;7(1):60-5. Review.

PMID:
8742378
4.

Current trends in the development of the electrochemiluminescent immunosensors.

Muzyka K.

Biosens Bioelectron. 2014 Apr 15;54:393-407. doi: 10.1016/j.bios.2013.11.011. Epub 2013 Nov 13. Review.

PMID:
24292145
5.

Solid supports for microarray immunoassays.

Kusnezow W, Hoheisel JD.

J Mol Recognit. 2003 Jul-Aug;16(4):165-76. Review.

PMID:
12898667
6.

Validation processes of protein biomarkers in serum--a cross platform comparison.

Köhler K, Seitz H.

Sensors (Basel). 2012;12(9):12710-28. doi: 10.3390/s120912710. Epub 2012 Sep 18. Review.

7.

Miniaturized immunoassays: moving beyond the microplate.

Verch T, Bakhtiar R.

Bioanalysis. 2012 Jan;4(2):177-88. doi: 10.4155/bio.11.301. Review.

PMID:
22250800
8.

Emerging technologies to increase ligand binding assay sensitivity.

Fischer SK, Joyce A, Spengler M, Yang TY, Zhuang Y, Fjording MS, Mikulskis A.

AAPS J. 2015 Jan;17(1):93-101. doi: 10.1208/s12248-014-9682-8. Epub 2014 Oct 18. Review.

9.

Comparative multicentre study of a panel of thyroid tests using different automated immunoassay platforms and specimens at high risk of antibody interference.

Martel J, Després N, Ahnadi CE, Lachance JF, Monticello JE, Fink G, Ardemagni A, Banfi G, Tovey J, Dykes P, John R, Jeffery J, Grant AM.

Clin Chem Lab Med. 2000 Aug;38(8):785-93.

PMID:
11071074
10.

Immunochemical analysis for dioxins--progress and prospects.

Harrison RO, Eduljee GH.

Sci Total Environ. 1999 Oct 1;239(1-3):1-18. Review.

PMID:
10570831
11.

Antibody microarrays for label-free cell-based applications.

Milgram S, Bombera R, Livache T, Roupioz Y.

Methods. 2012 Feb;56(2):326-33. doi: 10.1016/j.ymeth.2011.10.016. Epub 2011 Dec 22.

PMID:
22200606
12.

Analytical assay platforms for soluble target engagement biomarkers: old favorites and emerging technologies.

Goodman J, Agoram B.

Bioanalysis. 2013 Dec;5(23):2919-31. doi: 10.4155/bio.13.262. Review.

PMID:
24295118
13.

Antibody microarrays: the crucial impact of mass transport on assay kinetics and sensitivity.

Kusnezow W, Syagailo YV, Goychuk I, Hoheisel JD, Wild DG.

Expert Rev Mol Diagn. 2006 Jan;6(1):111-24. Review.

PMID:
16359272
14.

Recent developments in protein microarray technology.

Wilson DS, Nock S.

Angew Chem Int Ed Engl. 2003 Feb 3;42(5):494-500. Review.

PMID:
12569479
15.

Solution ELISA as a platform of choice for development of robust, drug tolerant immunogenicity assays in support of drug development.

Mikulskis A, Yeung D, Subramanyam M, Amaravadi L.

J Immunol Methods. 2011 Feb 28;365(1-2):38-49. doi: 10.1016/j.jim.2010.11.011. Epub 2010 Dec 1.

PMID:
21130095
16.

Thyroid hormone testing in the 21st century.

Singh RJ, Kaur P.

Clin Biochem. 2016 Aug;49(12):843-5. doi: 10.1016/j.clinbiochem.2016.06.007. Epub 2016 Jun 18.

PMID:
27329994
17.

Amperometric immunoassay.

Monroe D.

Crit Rev Clin Lab Sci. 1990;28(1):1-18. Review.

PMID:
2222796
18.

Immunoaffinity chromatography: an introduction to applications and recent developments.

Moser AC, Hage DS.

Bioanalysis. 2010 Apr;2(4):769-90. doi: 10.4155/bio.10.31. Review.

19.

Taguchi design-based optimization of sandwich immunoassay microarrays for detecting breast cancer biomarkers.

Luo W, Pla-Roca M, Juncker D.

Anal Chem. 2011 Jul 15;83(14):5767-74. doi: 10.1021/ac103239f. Epub 2011 Jun 23.

PMID:
21667934
20.

Capillary electrophoresis-based immunoassay.

Yeung WS, Luo GA, Wang QG, Ou JP.

J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Nov 25;797(1-2):217-28. Review.

PMID:
14630151

Supplemental Content

Support Center